Literature DB >> 17274481

Direct medical costs of constipation in the United States.

Bradley C Martin1, Victoria Barghout, Annamaria Cerulli.   

Abstract

This study estimated the total medical cost of care and described characteristics of patients with constipation in the United States. The 2001 National Ambulatory Medical Care Survey, National Hospital Ambulatory Medical Care Survey, and National Hospital Discharge Survey were used to provide national estimates. Patients diagnosed with constipation, or whose constipation was a reason for the visit, were identified. Medicare reimbursement rates based on recognized diagnostic and procedural codes were used to value each visit related to constipation. Constipation was a diagnosis or reason for seeking care in an estimated 5.7 million ambulatory visits and was the primary diagnosis or reason for 2.7 million of those visits. Of these visits, 1,838,493 were outpatient physician, 297,927 were outpatient hospital, and 555,432 were emergency department. Constipation was the primary diagnosis in 38,361 additional inpatient visits. Total cost was dollar 235 million per year, with 55% incurred from inpatient care and 23%, 16%, and 6% from ED, outpatient physician, and outpatient hospital settings, respectively. Constipation is treated primarily in ambulatory settings, but the costs of inpatient care exceed those of ambulatory care.

Entities:  

Mesh:

Year:  2006        PMID: 17274481

Source DB:  PubMed          Journal:  Manag Care Interface        ISSN: 1096-5645


  25 in total

1.  Chronic constipation: new diagnostic and treatment approaches.

Authors:  Brian E Lacy; John M Levenick; Michael Crowell
Journal:  Therap Adv Gastroenterol       Date:  2012-07       Impact factor: 4.409

2.  Linaclotide: a novel therapy for chronic constipation and constipation-predominant irritable bowel syndrome.

Authors:  Brian E Lacy; John M Levenick; Michael D Crowell
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-10

3.  Longitudinal direct medical costs associated with constipation in women.

Authors:  R S Choung; M E Branda; D Chitkara; N D Shah; S K Katusic; G R Locke; N J Talley
Journal:  Aliment Pharmacol Ther       Date:  2010-11-22       Impact factor: 8.171

Review 4.  Dyssynergic defecation and biofeedback therapy.

Authors:  Satish S C Rao
Journal:  Gastroenterol Clin North Am       Date:  2008-09       Impact factor: 3.806

Review 5.  American Gastroenterological Association technical review on constipation.

Authors:  Adil E Bharucha; John H Pemberton; G Richard Locke
Journal:  Gastroenterology       Date:  2013-01       Impact factor: 22.682

6.  Prescribing patterns for the outpatient treatment of constipation in the United States.

Authors:  Katy E Trinkley; Kyle Porter; Milap C Nahata
Journal:  Dig Dis Sci       Date:  2010-04-17       Impact factor: 3.199

Review 7.  Constipation in childhood.

Authors:  Suzanne M Mugie; Carlo Di Lorenzo; Marc A Benninga
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-08-02       Impact factor: 46.802

Review 8.  Chronic Constipation.

Authors:  Adil E Bharucha; Arnold Wald
Journal:  Mayo Clin Proc       Date:  2019-05-01       Impact factor: 7.616

Review 9.  Review of the treatment options for chronic constipation.

Authors:  John F Johanson
Journal:  MedGenMed       Date:  2007-05-02

10.  Prucalopride: the evidence for its use in the treatment of chronic constipation.

Authors:  Georges Coremans
Journal:  Core Evid       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.